Molecular mechanisms of cisplatin resistance in ovarian cancer
Genes & Diseases · 2024-11 · 11 (6) · 101063
DOI: 10.1016/j.gendis.2023.06.032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Diseases, 2024-11. Verfasst von Chenying Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ovarian cancer is one of the most common malignant tumors of the female reproductive system. The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy. As the most widely used first-line anti-neoplastic drug, cisplatin produces therapeutic effects through multiple mechanisms. However, during clinical treatment, cisplatin resistance has gradually emerged, representing a challenge for patient outcome improvement. The mechanism of cisplatin resistance, while known to be complex and involve many processes, remains unclear. We hope to provide a new direction for pre-clinical and clinical studies through this review on the mechanism of ovarian cancer cisplatin resistance and methods to overcome drug resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China.
- The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310005, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, C., Shen, C., Ni, M., Huang, L., Hu, H., Dai, Q., Zhao, H., & Zhu, Z. (2024). Molecular mechanisms of cisplatin resistance in ovarian cancer. Genes & Diseases, 11(6), 101063. https://doi.org/10.1016/j.gendis.2023.06.032
Vancouver
Jiang C, Shen C, Ni M, Huang L, Hu H, Dai Q, et al. Molecular mechanisms of cisplatin resistance in ovarian cancer. Genes & Diseases. 2024;11(6):101063. doi:10.1016/j.gendis.2023.06.032
BibTeX
@article{Jiang2024,
author = {Jiang, Chenying and Shen, Chenjun and Ni, Maowei and Huang, Lili and Hu, Hongtao and Dai, Qinhui and Zhao, Huajun and Zhu, Zhihui},
title = {Molecular mechanisms of cisplatin resistance in ovarian cancer},
journal = {Genes & Diseases},
year = {2024},
volume = {11},
number = {6},
pages = {101063},
doi = {10.1016/j.gendis.2023.06.032}
}
EUVIMED